Pharmsynthez Company Description

Public Joint-Stock Company "Pharmsynthez", a pharmaceutical company, researches, manufactures, and distributes officinal and generic active pharmaceutical ingredients in Russia, Europe, the United States, and CIS countries.

The company offers officinal medicines, including Neovir, Segidrin, Glaumax, Vazostenon, Neostim, Fludarabel, Fenazide, Fenasid, and Penkrofton that are used in oncology, gynecology, treatment of immune deficiencies, and tuberculosis.

Public Joint-Stock Company "Pharmsynthez" was founded in 1996 and is based in St. Petersburg, Russia.

Pharmsynthez

Country	Russia
Founded	1996
Industry	Pharmaceutical Preparations
CEO	Petr Kurglyakov

Contact Details

Address: 25 Krasnovo Kursanta Str St. Petersburg, 197 110 Russia
Phone	7 812 329 8080
Website	pharmsynthez.com

Stock Details

Ticker Symbol	LIFE
Exchange	Moscow Stock Exchange
Fiscal Year	January - December
Reporting Currency	RUB
SIC Code	2834

Key Executives

Name	Position
Petr Kurglyakov	Chief Executive Officer